- Home
- ERNA vs EKSO Comparison
ERNA vs EKSO Comparison
Compare ERNA & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERNA
- EKSO
- Stock Information
- Founded
- ERNA 2018
- EKSO 2005
- Country
- ERNA United States
- EKSO United States
- Employees
- ERNA N/A
- EKSO N/A
- Industry
- ERNA Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- ERNA Health Care
- EKSO Health Care
- Exchange
- ERNA Nasdaq
- EKSO Nasdaq
- Market Cap
- ERNA 15.8M
- EKSO 13.4M
- IPO Year
- ERNA N/A
- EKSO N/A
- Fundamental
- Price
- ERNA $0.31
- EKSO $0.55
- Analyst Decision
- ERNA
- EKSO Strong Buy
- Analyst Count
- ERNA 0
- EKSO 2
- Target Price
- ERNA N/A
- EKSO $5.50
- AVG Volume (30 Days)
- ERNA 662.5K
- EKSO 318.5K
- Earning Date
- ERNA 03-13-2025
- EKSO 03-03-2025
- Dividend Yield
- ERNA N/A
- EKSO N/A
- EPS Growth
- ERNA N/A
- EKSO N/A
- EPS
- ERNA N/A
- EKSO N/A
- Revenue
- ERNA $598,000.00
- EKSO $17,682,000.00
- Revenue This Year
- ERNA N/A
- EKSO N/A
- Revenue Next Year
- ERNA N/A
- EKSO $32.74
- P/E Ratio
- ERNA N/A
- EKSO N/A
- Revenue Growth
- ERNA 1072.55
- EKSO 4.12
- 52 Week Low
- ERNA $0.22
- EKSO $0.47
- 52 Week High
- ERNA $2.63
- EKSO $2.16
- Technical
- Relative Strength Index (RSI)
- ERNA 44.59
- EKSO 42.05
- Support Level
- ERNA $0.25
- EKSO $0.50
- Resistance Level
- ERNA $0.37
- EKSO $0.61
- Average True Range (ATR)
- ERNA 0.04
- EKSO 0.04
- MACD
- ERNA -0.00
- EKSO 0.00
- Stochastic Oscillator
- ERNA 54.08
- EKSO 57.33
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.